P82 Efficacy of double-blinding in a randomized controlled trial (RCT) of low dose warfarin to prevent thromboembolic disease in patients with metastatic breast cancer
โ Scribed by Lenore Dickson; Mark Levine; Michael Gent
- Book ID
- 113297889
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 83 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0197-2456
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place
Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre